GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » YoY EBITDA Growth

PT Bundamedik Tbk (ISX:BMHS) YoY EBITDA Growth : -20.36% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PT Bundamedik Tbk's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -20.36%.

PT Bundamedik Tbk's EBITDA per Share for the three months ended in Mar. 2025 was Rp6.35.


PT Bundamedik Tbk YoY EBITDA Growth Historical Data

The historical data trend for PT Bundamedik Tbk's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk YoY EBITDA Growth Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 68.44 287.06 -66.17 -37.07 4.44

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.07 59.34 2.53 -33.24 -20.36

PT Bundamedik Tbk YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PT Bundamedik Tbk's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(24.697-23.647)/ | 23.647 |
=4.44 %

PT Bundamedik Tbk's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(6.349-7.972)/ | 7.972 |
=-20.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Bundamedik Tbk YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk Headlines

No Headlines